Zyversa Therapeutics Inc Stock Ownership - Who owns Zyversa Therapeutics?

Insider buying vs selling

Have Zyversa Therapeutics Inc insiders been buying or selling?
Peter WolfeChief Financial Officer2022-12-163,000$2.88

1 of 1

ZVSA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ZVSA insiders and whales buy or sell their stock.

ZVSA Shareholders

What type of owners hold Zyversa Therapeutics Inc stock?
Incon Co Ltd120.41%1,497,199$3.20MInsider
Daniel J. Oconnor110.79%1,377,598$2.95MInsider
Walleye Capital LLC78.86%980,568$2.10MInstitution
Stephen C. Glover39.63%492,756$1.05MInsider
Agp Alliance Global Partners Corp35.94%446,843$956.24kInsider
Larkspur Health LLC19.00%236,273$505.62kInsider
Geode Capital Management LLC9.90%123,130$263.50kInstitution
Cowen And Company LLC4.02%50,000$107.00kInstitution
Peter Wolfe3.59%44,585$95.41kInsider
Pablo A. Guzman2.09%26,021$55.68kInsider

1 of 3

ZVSA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ZVSA22.95%77.05%Net Buying
ADTX1.33%98.67%Net Selling
AMPE0.04%99.96%Net Buying
PXMD3.98%96.02%Net SellingNet Selling

Zyversa Therapeutics Stock Ownership FAQ

Who owns Zyversa Therapeutics?

Zyversa Therapeutics (NASDAQ: ZVSA) is owned by 99.39% institutional shareholders, 333.77% Zyversa Therapeutics insiders, and 0.00% retail investors. Incon Co Ltd is the largest individual Zyversa Therapeutics shareholder, owning 1.50M shares representing 120.41% of the company. Incon Co Ltd's Zyversa Therapeutics shares are currently valued at $1.72M.

If you're new to stock investing, here's how to buy Zyversa Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.